Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICON8 Trials Programme
2010-022209-16Phase 3Unknown
- Sponsor
- University College London
- Start
- Dec 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of carboplatin, paclitaxel and bevacizumab in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by University College London. Primary endpoints: ICON8 stage 1 outcomes, ICON8 stage 2 outcomes and 1 more. Status: unknown.
02
Drugs
carboplatinpaclitaxelbevacizumab
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on 2010-022209-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022209-16.